← Eichor
Study identifier: NCT06780475 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Validation of in Vitro Method for Anti-MCPyV Immunotherapy on Patients With Cutaneous Merkel Cell Carcinoma

Condition: Merkel Cell Carcinoma of Skin  ·  Sponsor: Assistance Publique - Hôpitaux de Paris

PhaseN/A
Planned participants15
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The aim of the study is to test and validate in vitro a cell therapy approach for MCPyV+ Merkel Cell Carcinoma patients.

This description comes directly from the study's public registry record.

Talk to the study team

Astrid Blom, MD  ·  +33 (01) 49 09 44 82  ·  astrid.blom@aphp.fr

Yassine Taoufik, MD, PhD  ·  yassine.taoufik@aphp.fr

Always discuss trial participation with your own doctor first.

Locations (1)

Dermato-oncology Department, Ambroise Paré Hospital, APHPBoulogne-Billancourt, FranceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06780475